EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Trend in the use of antidepressant pharmacotherapy and diagnosis of depression in the US An assessment of office-based visits 1990 to 1998



Trend in the use of antidepressant pharmacotherapy and diagnosis of depression in the US An assessment of office-based visits 1990 to 1998



CNS Drugs 14(6): 473-481, December




(PDF 0-2 workdays service: $29.90)

Accession: 035985065

Download citation: RISBibTeXText



Related references

Trends in the prescribing of antidepressant pharmacotherapy: office-based visits, 1990-1995. Clinical Therapeutics 20(4): 871-84; 870, 1998

Trends in the rate of depressive illness and use of antidepressant pharmacotherapy by ethnicity/race: An assessment of office-based visits in the United States, 1992-1997. Clinical Therapeutics 22(12): 1575-1589, December, 2000

Trends in the rate of depressive illness and use of antidepressant pharmacotherapy by ethnicity/race: an assessment of office-based visits in the United States, 1992-1997. Clinical Therapeutics 22(12): 1575-1589, 2001

Trend in the Use of Antidepressant Pharmacotherapy and Diagnosis of Depression in the US. Cns Drugs 14(6): 473-481, 2000

Anxiety disorders in the USA, 1990 to 1997: Trend in complaint, diagnosis, use of pharmacotherapy and diagnosis of comorbid depression. Clinical Drug Investigation 20(4): 255-265, October, 2000

What factors influence the prescribing of antidepressant pharmacotherapy? An assessment of national office-based encounters. International Journal of Psychiatry in Medicine 28(4): 407-419, 1999

What Factors Influence the Prescribing of Antidepressant Pharmacotherapy? An Assessment of National Office-Based Encounters. International Journal of Psychiatry in Medicine 28(4): 407-419, 1998

Provision of Lifestyle Counseling and the Prescribing of Pharmacotherapy for Hyperlipidemia Among US Ambulatory Patients: A National Assessment of Office-Based Physician Visits. American Journal of Cardiovascular Drugs, 2017

Seasonal variation of dermatologic disease in the USA: a study of office visits from 1990 to 1998. International Journal of Dermatology 43(1): 6-11, 2004

Seasonal variation of dermatologic disease in the USA: a study of office visits from 1990 to 1998. International Journal of Dermatology 43(1): 6-11, 2003

Diagnosis of depression and use of antidepressant pharmacotherapy among adults in the United States: does a disparity persist by ethnicity/race?. Clinical Drug Investigation 32(2): 139-144, 2012

Ethnicity/race, use of pharmacotherapy, scope of physician-ordered cholesterol screening, and provision of diet/nutrition or exercise counseling during US office-based visits by patients with hyperlipidemia. American Journal of Cardiovascular Drugs 10(2): 105-108, 2010

Antidepressant monotherapy vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recurrent depression. Archives of General Psychiatry 67(12): 1256-1264, 2011

Characteristics of office-based physician visits for cutaneous fungal infections. an analysis of 1990 to 1994 National Ambulatory Medical Care Survey Data. Cutis 69(3): 191-8, 201-2, 2002

Assessment of the incidence of psoriasis based on data from office visits and medical examinations. Vestnik Dermatologii i Venerologii: 46-48, 1985